Position history for DnB Asset Management AS's holdings in NEUROCRINE BIOSCIENCES INC
DnB Asset Management AS holds 141,232 shares of NBIX (NEUROCRINE BIOSCIENCES INC), worth $18.6M as of 2026-Q1. The position was increased (+1.3% shares). NBIX represents 0.1% of DnB Asset Management AS's portfolio.
Current Value
$18.6M
Current Shares
141,232
Total Value Change
+$8.3M
Total Shares Change
+66,286
Other major holders of NBIX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 141,232 |
+1.3% |
| $18.6M |
| 0.1% |
| $131.14 |
29 |
| 2025-Q4 | Increased | 139,457 | +12.4% | $19.8M | 0.1% | $140.95 | 32 |
| 2025-Q3 | Increased | 124,108 | +8.0% | $17.4M | 0.1% | $140.27 | 31 |
| 2025-Q2 | Decreased | 114,940 | -10.3% | $14.4M | 0.1% | $125.42 | 0 |
| 2025-Q1 | Increased | 128,112 | +8.4% | $14.2M | 0.1% | $113.16 | 30 |
| 2024-Q4 | Increased | 118,227 | +3.0% | $16.1M | 0.1% | $137.06 | 29 |
| 2024-Q3 | Increased | 114,727 | +53.1% | $13.2M | 0.1% | $115.06 | 39 |
| 2024-Q2 | Increased | 74,946 | +17.2% | $10.3M | 0.0% | $137.67 | 32 |